Hypoglycemia | Page 3 of 4

Hypoglycemia Common Among Type 2 Diabetes Patients Treated with Insulin

According to the GAPP2™ (Global Attitudes of Patients and Physicians) survey, funded by Novo Nordisk and presented today at the Annual Meeting of the European Association for the Study of Diabetes (EASD), four out of five (80%) people with type 2 diabetes have experienced self-treated hypoglycemia...

Hypoglycemia Unawareness: Has It Arrived?

Yesterday I told Jessica that I felt a little like someone with type 2 diabetes. My numbers rarely go over 200 and I haven’t had any episodes of severe…

Lilly Diabetes Launches Glucagon Mobile App

Lilly Diabetes today announced the release of a new mobile application designed for caregivers and healthcare providers who support people with type 1 diabetes. The Lilly Glucagon Mobile App is a tool to teach how to use Glucagon for injection, through simulated practice. Glucagon, 1 mg (1 unit), is indicated to treat severe hypoglycemia (low blood sugar). Severe hypoglycemia due to insulin may result in loss of consciousness (insulin coma).

Risks of Marathon Running and Hypoglycemia in Type 1 Diabetes

A friend of mine sent me a link yesterday to an article titled Risks of Marathon Running and Hypoglycemia in Type 1 Diabetes with a note, “please be…

Treating Hypoglycemia: A Chance to Revert to Toddler Behavior

At something like 4:30 AM on this past Thursday morning, my CGMS woke me up with the “low” alarm. Hypoglycemia. I always keep my receiver in bed…

Losing to Diabetes and Learning from It

Milestones I’ve experienced in the past week: receiving a new glasses prescription, acquiring a queen-sized bed, and ending the “Honeymoon…

New Novo Nordisk Insulin Reduces Risk of Nighttime Hypoglycemia, New Studies Show

Novo Nordisk's ultra long-acting basal insulin Degludec significantly reduces risk of hypoglycemia during the night compared to insulin glargine, according to two long-term studies. The company announced the clinical results from two 52-week phase 3a treat-to-target studies comparing Degludec to insulin glargine in basal-bolus treatment of type 1 and type 2 diabetes...